Page last updated: 2024-09-04

n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and 3-hydroxybenzylhydrazine

n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide has been researched along with 3-hydroxybenzylhydrazine in 1 studies

Compound Research Comparison

Studies
(n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide)
Trials
(n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide)
Recent Studies (post-2010)
(n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide)
Studies
(3-hydroxybenzylhydrazine)
Trials
(3-hydroxybenzylhydrazine)
Recent Studies (post-2010) (3-hydroxybenzylhydrazine)
1400273016

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldessarini, RJ; Huston-Lyons, D; Marsh, ER1

Other Studies

1 other study(ies) available for n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and 3-hydroxybenzylhydrazine

ArticleYear
Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.
    Biochemical pharmacology, 1994, May-18, Volume: 47, Issue:10

    Topics: 4-Butyrolactone; Animals; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Extrapyramidal Tracts; Hydrazines; Limbic System; Male; Rats; Rats, Sprague-Dawley

1994